The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Abstract
Drugs of abuse are very powerful reinforcers, and even in conditions of limited access (where the organism is not dependent) these drugs will motivate high rates of operant responding. This presumed hedonic property and the drugs' neuropharmacological specificity provide a means of studying the neuropharmacology and neuroanatomy of brain reward. Three major brain systems appear to be involved in drug reward--dopamine, opioid and GABA. Evidence suggests a midbrain-forebrain-extrapyramidal circuit with its focus in the nucleus accumbens. Data implicating dopamine and opioid systems in indirect sympathomimetic and opiate reward include critical elements in both the nucleus accumbens and ventral tegmental areas. Ethanol reward appears to depend on an interaction with the GABAA receptor complex but may also involve common elements such as dopamine and opioid peptides in this midbrain-forebrain-extrapyramidal circuit. These results suggest that brain reward systems have a multidetermined neuropharmacological basis that may involve some common neuroanatomical elements.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, there is extensive experimental evidence in animal contexts supporting a role for the mesolimbic reward pathway on appetitive and motivational behaviors [306,307].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [307]
In the citing paper
“The meso-limbic dopamine system that projects from the ventral tegmental area (VTA) to the nucleus accumbens has been implicated in the rewarding effects of drugs of abuse”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Koob, 1992
Citations
Cites
Handbook of Psychopharmacology
Iversen, L. L., Iversen, S. D., & Snyder, S. H. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,756
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationWise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
An opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Fallon, J. H., & Moore, R. Y. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901800310 · Cited by 1,190
Mesocorticolimbic dopaminergic network: functional and regulatory roles
Moal, M. L., & Simon, H. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.155 · Cited by 1,108
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Research works printed but not linked: 21
- Dahlström, 1964, Acta Physiol. Scand., 232, 1
- Weiss, F. et al.Ann. NY Acad. Sci. (in press).
- Pfeffer, 1985, Alcohol Drug Res., 6, 37
- Rassnick, S., Pulvirenti, L. and Koob, G. F. Psychopharmacology (in press).
- Samson, 1988, Alcohol. Clin. Exp. Res., 12, 581
- Imperato, 1986, J. Pharmacol. Exp. Ther., 239, 221
- Bodnar, 1990, Crit. Rev. Neurobiol., 6, 39
- West, 1989, Soc. Neurosri. Abstr., 15, 20.8
- Koob, 1984, J. Pharmacol. Exp. Ther., 229, 481
- Goldberg, 1971, J. Pharmacol. Exp. Ther., 176, 464
- Di Chiara, 1988, J. Pharmacol. Exp. Ther., 244, 1067
- Di Chiara, 1988, 85, 5274
- Shippenberg, T. S., Spanagel, R. and Herz, A.Ann. NY Acad. Sci. (in press).
- Givens, 1990, J. Pharmacol. Exp. Ther., 254, 528
- Sepinwall, 1978, Vol. 13, 345
- Koob, G. F. and Britton, K. T. in Pharmacology and Neuropharmacology (Vol. 2) Alcohol and Alcoholisms (Begleiter, H. and Kissin, B., eds), Oxford University Press (in press).
- Frye, 1982, J. Pharmacol. Exp. Ther., 223, 750
- Suzdak, 1986, 83, 4071
- Rassnick, S. et al.Ann. NY Acad. Sci. (in press).
- Deitrich, 1989, Pharmacol. Rev., 41, 489
- Pickens, 1981, J. Pharmacol. Exp. Ther., 216, 205
Cited by
Sorted by citations
Items 101–200 of 1,004
Maternal Smoking During Pregnancy and Psychopathology in Offspring Followed to Adulthood
Weissman, M. M., Warner, V., WICKRAMARATNE, P. J., & Kandel, D. B. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199907000-00020 · Cited by 346
Decreased brain reward produced by ethanol withdrawal
Schulteis, G., Markou, A., Cole, M., & Koob, G. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.5880 · Cited by 345
Self-citationBuprenorphine: A Unique Drug with Complex Pharmacology
Lutfy, K., & Cowan, A. (2004) · Current Neuropharmacology · doi:10.2174/1570159043359477 · Cited by 343
Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location
Ford, C. P., Mark, G. P., & Williams, J. T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4331-05.2006 · Cited by 339
Fon, E. A., Pothos, E. N., Sun, B.-C., Killeen, N. P., Sulzer, D., & Edwards, R. H. (1997) · Neuron · doi:10.1016/s0896-6273(00)80418-3 · Cited by 339
Lieberman, J. A. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00045-6 · Cited by 335
Xu, M., Hu, X., Cooper, D., Moratalla, R., Graybiel, A. M., White, F. J., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90026-4 · Cited by 333
WOLFFGRAMM, J. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00131-c · Cited by 331
GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain
Bockstaele, E. J. V., & Pickel, V. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00334-m · Cited by 329
Nicotine Dependence in the United States
Breslau, N., Johnson, E. O., Hiripi, E., & Kessler, R. C. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.810 · Cited by 328
Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor
Rocha, B. A. G., Scearce-Levie, K. A., Lucas, J. J., Hiroi, N., Castanon, N., Crabbe, J. C., Nestler, E. J., & Hen, R. (1998) · Nature · doi:10.1038/30259 · Cited by 327
Self, D. W., Genova, L. M., Hope, B. T., Barnhart, W. J., Spencer, J. J., & Nestler, E. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01848.1998 · Cited by 325
Berhow, M. T., Hiroi, N., & Nestler, E. J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-15-04707.1996 · Cited by 323
The Role of the Striatopallidal and Extended Amygdala Systems in Drug Addiction
Koob, G. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09282.x · Cited by 322
Self-citationAddiction and its reward process through polymorphisms of the D2dopamine receptor gene: a review
Noble, E. P. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00208-x · Cited by 320
Student Perceptions of Methylphenidate Abuse at a Public Liberal Arts College
Babcock, Q., & Byrne, T. (2000) · Journal of American College Health · doi:10.1080/07448480009596296 · Cited by 318
Oswald, L. M., Wong, D. F., McCaul, M., Zhou, Y., Kuwabara, H., Choi, L., Brasic, J., & Wand, G. S. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300667 · Cited by 314
Piazza, P. V., Deroche‐Gamonet, V., Deminière, J.-M., Maccari, S., Moal, M. L., & Simon, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11738 · Cited by 313
What Keeps Us Awake: the Neuropharmacology of Stimulants and Wakefulness Promoting Medications
Boutrel, B., & Koob, G. F. (2004) · SLEEP · doi:10.1093/sleep/27.6.1181 · Cited by 310
Self-citationShould the scope of addictive behaviors be broadened to include pathological gambling?
Petry, N. M. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01593.x · Cited by 305
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
van Ree, J. M., Gerrits, M. A. F. M., & Vanderschuren, L. J. M. J. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01405-4 · Cited by 301
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Olive, M. F., Koenig, H. N., Nannini, M., & Hodge, C. W. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-j0002.2001 · Cited by 299
Effects of Ethanol on Ion Channels
Crews, F. T., Morrow, A. L., Criswell, H. E., & Breese, G. R. (1996) · International review of neurobiology · doi:10.1016/s0074-7742(08)60670-4 · Cited by 296
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
Foll, B. L., & Goldberg, S. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.077974 · Cited by 294
D2 and D4 dopamine receptor polymorphisms and personality
Noble, E. P., Ozkaragoz, T. Z., Ritchie, T. L., Zhang, X., Belin, T. R., & Sparkes, R. S. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980508)81:3 · Cited by 292
Synaptic regulation of mesocorticolimbic dopamine neurons
White, F. J. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.002201 · Cited by 289
Heimer, L., Harlan, R. E., Alheid, G. F., Garcia, M. M., & de Olmos, J. S. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00405-8 · Cited by 289
Tanda, G., & Goldberg, S. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1485-z · Cited by 288
Drugs as instruments: A new framework for non-addictive psychoactive drug use
Müller, C. P., & Schumann, G. (2011) · Behavioral and Brain Sciences · doi:10.1017/s0140525x11000057 · Cited by 286
Transient changes in mesolimbic dopamine and their association with ‘reward’
Wightman, R. M., & Robinson, D. L. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01005.x · Cited by 285
Neuroadaptive mechanisms of addiction: studies on the extended amygdala
Koob, G. F. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.005 · Cited by 285
Self-citationHigher Expression of Serotonin 5-HT2A Receptors in the Postmortem Brains of Teenage Suicide Victims
Pandey, G. N., Dwivedi, Y., Rizavi, H. S., Ren, X., Pandey, S. C., Pesold, C., Roberts, R. C., Conley, R. R., & Tamminga, C. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.419 · Cited by 282
The Dopamine Hypothesis of Drug Addiction: Hypodopaminergic State
Melis, M., Spiga, S., & Diana, M. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)63005-x · Cited by 282
Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons.
Sklair‐Tavron, L., Shi, W. X., Lane, S. B., Harris, H. W., Bunney, B. S., & Nestler, E. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11202 · Cited by 279
Glutamatergic mechanisms in addiction
Tzschentke, T., & Schmidt, W. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001269 · Cited by 277
Mukherjee, J., Christian, B. T., Dunigan, K. A., Shi, B., Narayanan, T. K., Satter, M. R., & Mantil, J. (2002) · Synapse · doi:10.1002/syn.10128 · Cited by 277
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse
Cossu, G., Ledent, C. A., Fattore, L., Impérato, A., Böhme, G. A., Parmentier, M., & Fratta, W. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00311-9 · Cited by 275
Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid Receptors
Ghozland, S. G., Matthes, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., & Maldonado, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01146.2002 · Cited by 272
Shared and unique mechanisms underlying binge eating disorder and addictive disorders
Schulte, E. M., Grilo, C. M., & Gearhardt, A. N. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.02.001 · Cited by 271
Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis
Ma, Y. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.24 · Cited by 270
A genetic association for cigarette smoking behavior.
Sabol, S. Z., Nelson, M. L., Fisher, C., Gunzerath, L., Brody, C., Hu, S., Sirota, L. A., Marcus, S. E., Greenberg, B. D., R., I. L. F., et al. (1999) · Health Psychology · doi:10.1037//0278-6133.18.1.7 · Cited by 269
Gilman, J. M., Ramchandani, V. A., Davis, M. B., Bjork, J. M., & Hommer, D. W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0086-08.2008 · Cited by 267
“, 2004), and support Koob’s (1992) hypothesis that all drugs of abuse activate the striatum.”
BackgroundSkibicka, K. P., Hansson, C., Egecioglu, E., & Dickson, S. L. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00294.x · Cited by 267
Maternal smoking during pregnancy and smoking by adolescent daughters.
Kandel, D. B., Wu, P., & Davies, M. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.9.1407 · Cited by 266
Neural Circuit Motifs in Valence Processing
Tye, K. M. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.001 · Cited by 268
Acetylcholine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders
Lester, D. B., Rogers, T. D., & Blaha, C. D. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00142.x · Cited by 267
Koya, E., Golden, S. A., Harvey, B. K., Guez‐Barber, D., Berkow, A., Simmons, D. E., Bossert, J. M., Nair, S. G., Uejima, J. L., Marin, M. T., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2364 · Cited by 263
Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice
Hwang, D. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00162-1 · Cited by 262
New developments in brain research of internet and gaming disorder
Weinstein, A., Livny, A., & Weizman, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.040 · Cited by 257
Similar roles of substantia nigra and ventral tegmental dopamine neurons in reward and aversion
Ilango, A., Kesner, A. J., Keller, K. L., Stuber, G. D., Bonci, A., & Ikemoto, S. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1703-13.2014 · Cited by 255
The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addiction
Dileone, R., Taylor, J. R., & Picciotto, M. R. (2012) · Nature Neuroscience · doi:10.1038/nn.3202 · Cited by 255
Dynamics of Neuronal Circuits in Addiction: Reward, Antireward, and Emotional Memory
Koob, G. F. (2009) · Pharmacopsychiatry · doi:10.1055/s-0029-1216356 · Cited by 254
Self-citationA role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior
Cornish, J. L., Duffy, P., & Kalivas, P. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00214-6 · Cited by 254
Hazardous drinking and alcohol use disorders
MacKillop, J. M., Agabio, R., Ewing, S. W. F., Heilig, M. A., Kelly, J. F., Leggio, L., Lingford-Hughes, A. R., Palmer, A. A., Parry, C. D. H., Ray, L. A., et al. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00406-1 · Cited by 251
The Neuroscience of Religious Experience
McNamara, P. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511605529 · Cited by 250
Dopamine Modulates Release from Corticostriatal Terminals
Bamford, N. S., Robinson, S., Palmiter, R. D., Joyce, J. A., Moore, C., & Meshul, C. K. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2891-04.2004 · Cited by 248
Motivation-dependent responses in the human caudate nucleus.
Delgado, M. R. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh062 · Cited by 246
Marubio, L. M., Gardier, A. M., Durier, S., David, D., Klink, R., Arroyo‐Jimenez, M. M., McIntosh, J. M., Rossi, F., Champtiaux, N., Zoli, M., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02564.x · Cited by 242
Stress, alcohol and drug interaction: an update of human research
Uhart, M., & Wand, G. S. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00131.x · Cited by 240
The roles of the reward system in sleep and dreaming
Perogamvros, L., & Schwartz, S. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.05.010 · Cited by 239
Neurocircuitry of alcohol addiction
Koob, G. F. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62619-6.00003-3 · Cited by 238
Self-citationMatthews, K., & Robbins, T. W. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00008-3 · Cited by 237
Chapter 1. Neurocircuitry of Addiction
Koob, G. F., & Volkow, N. D. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb01 · Cited by 236
Self-citationOswald, L. M., & Wand, G. S. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.02.008 · Cited by 235
Blomqvist, O., Ericson, M., Johnson, D. H., Engel, J. A., & Söderpalm, B. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00583-3 · Cited by 235
μ-Opposing actions of the κ-opioid receptor
Pan, Z. Z. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01169-9 · Cited by 234
Kitchen, I., Slowe, S. J., Matthes, H. W. D., & Kieffer, B. L. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00988-8 · Cited by 234
Kerns, R. T., Ravindranathan, A., Hassan, S., Cage, M. P., York, T., Sikela, J. M., Williams, R. W., & Miles, M. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4372-04.2005 · Cited by 232
Kauer, J. A. (2004) · Annual Review of Physiology · doi:10.1146/annurev.physiol.66.032102.112534 · Cited by 232
Case-Control Study of the D2 Dopamine Receptor Gene and Smoking Status in Lung Cancer Patients
Spitz, M. R., Shi, H., Yang, F., Hudmon, K. S., Jiang, H., Chamberlain, R. M., Amos, C. I., Wan, Y., Wu, X., Cinciripini, P. M., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.5.358 · Cited by 230
Möller, C., Wiklund, L., Sommer, W., Thorsell, A., & Heilig, M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00308-9 · Cited by 229
Recent Advances in the Detection of Neurotransmitters
Si, B., & Song, E. (2018) · Chemosensors · doi:10.3390/chemosensors6010001 · Cited by 229
Zhang, L., Lou, D., Jiao, H., Zhang, D., Wang, X., Xia, Y., Zhang, J., & Xu, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0060-04.2004 · Cited by 228
Smoking Bans in Psychiatric Inpatient Settings? A Review of the Research
Lawn, S., & Pols, R. G. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01697.x · Cited by 227
Basal ganglia circuit loops, dopamine and motivation: a review and enquiry
Ikemoto, S., Yang, C., & Tan, A. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.018 · Cited by 226
“This view of DA’s unctions has been derived, in part, from research on drugs of abuse, nd thus DA is thought to play a key role in reward action of abused rugs [5–7].”
Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol
Söderpalm, B., Ericson, M., Olausson, P., Blomqvist, O., & Engel, J. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00203-5 · Cited by 226
Shirayama, Y., & Chaki, S. (2006) · Current Neuropharmacology · doi:10.2174/157015906778520773 · Cited by 225
Neurochemical and behavioral studies on ethanol and nicotine interactions
Larsson, A. C., & Engel, J. A. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.11.010 · Cited by 224
Critical assessment of how to study addiction and its treatment: Human and non-human animal models
O’Brien, C. P., & Gardner, E. L. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.018 · Cited by 224
Conditioned taste aversions and drugs of abuse: A reinterpretation.
Grigson, P. S. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.1.129 · Cited by 224
See, R. E., Kruzich, P. J., & Grimm, J. W. (2001) · Psychopharmacology · doi:10.1007/s002130000636 · Cited by 224
Parallel developmental trajectories of sensation seeking and regular substance use in adolescents.
Crawford, A. M., Pentz, M. A., Chou, C., Li, C., & Dwyer, J. H. (2003) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.17.3.179 · Cited by 221
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
Bohn, L., Gainetdinov, R. R., Sotnikova, T. D., Medvedev, I. O., Lefkowitz, R. J., Dykstra, L., & Caron, M. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10265.2003 · Cited by 218
Synchrony as an Adaptive Mechanism for Large‐Scale Human Social Bonding
Launay, J., Tarr, B., & Dunbar, R. (2016) · Ethology · doi:10.1111/eth.12528 · Cited by 218
Vries, T. J. D., Schoffelmeer, A. N. M., Binnekade, R., & Vanderschuren, L. J. M. J. (1999) · Psychopharmacology · doi:10.1007/s002130050944 · Cited by 218
A G-Protein-Coupled Estrogen Receptor Is Involved in Hypothalamic Control of Energy Homeostasis
Qiu, J., Bosch, M. A., Tobias, S. C., Krust, A., Graham, S. M., Murphy, S. J., Korach, K. S., Chambon, P., Scanlan, T. S., Rønnekleiv, O. K., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0327-06.2006 · Cited by 217
Zebrafish models in neuropsychopharmacology and CNS drug discovery
Khan, K. M., Collier, A. D., Мешалкина, Д. А., Kysil, E. V., Khatsko, S. L., Kolesnikova, T. O., Morzherin, Y. Y., Warnick, J. E., Kalueff, A. V., & Echevarria, D. J. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13754 · Cited by 217
Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system
Ortiz, J., Fitzgerald, L. W., Charlton, M. E., Lane, S., Trevisan, L. A., Guitart, X., Shoemaker, W. J., Duman, R. S., & Nestler, E. J. (1995) · Synapse · doi:10.1002/syn.890210403 · Cited by 217
Morris, R., Pandya, D. Ν., & Petrides, M. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990503)407:2 · Cited by 219
Wolff, K., & WINSTOCK, A. R. (2006) · CNS Drugs · doi:10.2165/00023210-200620030-00003 · Cited by 214
Delfs, J. M., Kong, H., Mestek, A., Chen, Y., Yu, L., Reisine, T., & Chesselet, M. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903450104 · Cited by 213
Reid, M. S., Hsu, K., & Berger, S. P. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199710)27:2 · Cited by 212
Studies to Investigate the Role of 5-HT2C Receptors on Cocaine- and Food-Maintained Behavior
Grottick, A. J., Fletcher, P. J., & Higgins, G. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39021-4 · Cited by 211
Heinz, A., Löber, S., Georgi, A., Wrase, J., Hermann, D., Rey, E.-R., Wellek, S., & Mann, K. (2003) · Alcohol and Alcoholism · doi:10.1093/alcalc/agg005 · Cited by 210
Brody, A. L., Mandelkern, M. A., Olmstead, R. E., Scheibal, D., Hahn, E. L., Shiraga, S., Zamora-Paja, E., Farahi, J. B., Saxena, S., London, E. D., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.808 · Cited by 209
Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence
Liu, J. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00057-1 · Cited by 209
D2 dopamine receptor gene and cigarette smoking: A reward gene?
Noble, E. P., Jeor, S. T. S., Ritchie, T., Syndulko, K., Jeor, S. C. S., Fitch, R. J., Brunner, R. L., & Sparkes, R. S. (1994) · Medical Hypotheses · doi:10.1016/0306-9877(94)90127-9 · Cited by 209
Ability of Baclofen in Reducing Alcohol Intake and Withdrawal Severity: I???Preclinical Evidence
Colombo, G., Agabio, R., Carai, M. A. M., Lobina, C., Pani, M., Reali, R., Addolorato, G., & GESSA, G. L. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04554.x · Cited by 208
Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics
Tiihonen, J., Kuikka, J. T., Bergström, K., Hakola, P., Karhu, J., Ryynänen, O., & Föhr, J. (1995) · Nature Medicine · doi:10.1038/nm0795-654 · Cited by 208
Metadata
- Authors
- Koob, G. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Koob, George F.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 13
- Issue
- 5
- Pages
- 177-184
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2001865657
- Cited by
- 2,070
- References
- 73
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 17 · 2021: 28 · 2020: 30 · 2019: 28 · 2018: 46 · 2017: 42 · 2016: 43 · 2015: 37 · 2014: 58 · 2013: 53 · 2012: 53
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA-08459)
- National Institute on Drug Abuse (DA04043, DA04398, R01DA004398, R01DA004043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- drugs of abuse, brain reward system, dopamine, opioid system, GABA, nucleus accumbens, ventral tegmental area, ethanol reward, opioid reward, operant responding
- MeSH terms
- Animals, Brain, Humans, Reward, Illicit Drugs, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review